CONFERENCE COVERAGE SERIES
International Conference on Alzheimer's Disease 2006
Madrid, Spain
15 – 20 July 2006
Madrid: ICAD Conference Draws to a Close
The 10th International Conference on Alzheimer’s Disease and Related Disorders, ICAD for short, ended yesterday just outside the palatial capital of Spain...
Madrid: BACE Found to Have Big Job in Wrapping Motoneurons
By the wholly unscientific survey of a roving reporter, the single most convincing and surprising molecular biology story that stuck in the minds of scientists at the 10th ICAD meeting was...
Madrid: Why Do People Drop Out of Trials?
Designing AD trials well would seem to be challenge enough for clinicians in the Alzheimer disease field. But even once that’s done...
Madrid: Stressed Brain—SNP Carriers Can Have Cake and Eat It
Famous as they are for their powerful effects throughout the body, circulating stress hormones such as the glucocorticoid cortisol still pose somewhat of a riddle when it comes to...
Madrid: BACE News Roundup, Part 1
This is part 1 of our 3-part series.
Madrid: BACE News Roundup, Part 2
This is part 2 of our 3-part series.
Madrid: BACE News Roundup, Part 3
This is part 3 of our 3-part series.
Madrid: News from the Vaccine Front—Phase 2 Postmortem, Part 1
This is part 1 of our 3-part series.
Madrid: News from the Vaccine Front—Phase 1 Hopefuls
This is part 2 of our 3-part series.
Madrid: News from the Vaccine Front—Bloody Complicated?
This concludes our 3-part series.
Madrid: γ-secretase Dimers, A New Model, A Drug in Clinic
The 10th International Conference on Alzheimer’s Disease and Related Disorders, held earlier this month in Madrid, offered its share of data on...
Madrid: Clinical Trials Update—Where Do Things Stand?
This is Part 1 of a three-part report. See also <a href="/news/conference-coverage/madrid-pooled-antibody-cocktail-new-metal-quencher">Part 2</a> and <a href="/news/conference-coverage/madrid-highs-and-lows-insulin-connection">Part 3</a> of this report.
Madrid: Pooled Antibody Cocktail, New Metal Quencher
This is Part 2 of a three-part report. See also <a href="/news/conference-coverage/madrid-clinical-trials-update-where-do-things-stand">Intro/Part 1</a> and <a href="/news/conference-coverage/madrid-highs-and-lows-insulin-connection">Part 3</a> of this clinical trials update.
Madrid: Highs and Lows of The Insulin Connection
This is Part 3 of a three-part report. See also <a href="/news/conference-coverage/madrid-clinical-trials-update-where-do-things-stand">Intro/Part 1</a> and <a href="/news/conference-coverage/madrid-pooled-antibody-cocktail-new-metal-quencher">Part 2</a> of this clinical trials update. Also see <a href="/sites/default/files/legacy/images/new/TrialsUpdate1458.pdf" target="_new">PDF</a> of Part 3.
Madrid: Beyond Aβ—Learning, Age, DNA Damage, and Pai-1
This story closes our coverage of the 10th International Conference on Alzheimer’s Disease and Related Disorders, held last July in Madrid. See <a href="/sites/default/files/legacy/images/new/LaFerla1460.pdf">PDF</a> of this story.